Status:
RECRUITING
Exhaled Breath Condensate Biomarkers in CARAS
Lead Sponsor:
Henan University of Traditional Chinese Medicine
Conditions:
Combined Allergic Rhinitis and Asthma Syndrome
Eligibility:
All Genders
18-80 years
Brief Summary
To explore the differences in the expression of biomarkers in different sample types between the healthy population and different subgroups of the disease, and to screen for potential biomarkers in a ...
Eligibility Criteria
Inclusion
- Patients with AR, BA and CARAS who meet the Western medical diagnostic criteria;
- Chinese medical evidence consistent with lung qi deficiency evidence, phlegm-heat congestion of the lung evidence, or wind-heat offending the lung evidence;
- Age 18 to 80 years;
- Voluntarily accepted the study and signed an informed consent form;
- Not participated in other clinical studies within 1 month before enrollment.
Exclusion
- Patients with combined vasomotor rhinitis and eosinophilic non-allergic rhinitis, other non-allergic rhinitis diseases that can cause symptoms such as nasal congestion and runny nose;
- Patients who are participating in other drug trials;
- Patients with a combination of other serious systemic diseases;
- Pregnant or lactating women;
- Patients with confusion, disorders of consciousness, dementia, and various psychiatric disorders.
Key Trial Info
Start Date :
April 1 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
May 30 2025
Estimated Enrollment :
270 Patients enrolled
Trial Details
Trial ID
NCT06573450
Start Date
April 1 2023
End Date
May 30 2025
Last Update
August 28 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The First Affiliated Hospital of Henan University of Chinese Medicine
Henan, Zhengzhou, China